99mTc-labeling and in vitro characterization of N4- and N3S-RGDS-derivative peptides

被引：0
|
作者：
A. Perera Pintado
S. J. Mather
M. A. Stalteri
D. Allison
A. Prats Capote
A. Hernández Cairo
O. Reyes Acosta
M. Bequet Romero
机构：
[1] Centre for Clinical Research,Department Nuclear Medicine
[2] St Bartholomew’s Hospital,undefined
[3] Centre of Genetic Engineering and Biotechnology,undefined
来源：
Journal of Radioanalytical and Nuclear Chemistry | 2008年 / 275卷
关键词：
Peptide; High Performance Liquid Chromatography; Hybrid Peptide; Trifluoracetic Acid; Stannous Fluoride;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The aim of this work was to characterize the in vitro behavior of N4- and N3S-RGDS-derivative peptides labeled with 99mTc. Peptides AGGG-Abu-GRGDSPK-NH2 (F22) and C(acm)-GGG-Abu-GRGDSPK-NH2 (SMA1) were synthesized by solid phase. The stability of 99mTc-labeled peptides was assessed in a 30-fold molar excess of cysteine and in plasma. The affinity for plasma proteins was also evaluated. Labeling yield was >95% for both peptides. 99mTc-F22 was not stable in presence of cysteine, but 63% of 99mTc remained chelated to SMA1 up to 24 hours. Both peptides showed low affinity to plasma proteins. N3S-RGDS-derivative peptide (SMA1) showed more stable coordination binding with 99mTc and a higher stability in plasma with regard to N4-RGDS-derivative peptide (F22).
引用
收藏
页码：619 / 626
页数：7
相关论文
共 50 条
  • [1] 99mTc-labeling and in vitro characterization of N4- and N3S-RGDS-derivative peptides
    Pintado, A. Perera
    Mather, S. J.
    Stalteri, M. A.
    Allison, D.
    Capote, A. Prats
    Cairo, A. Hernandez
    Acosta, O. Reyes
    Romer, M. Bequet
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2008, 275 (03) : 619 - 626
  • [2] Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide
    Decristoforo, C
    Mather, SJ
    BIOCONJUGATE CHEMISTRY, 1999, 10 (03) : 431 - 438
  • [3] Preparation, 99mTc-labeling, and in vitro characterization of hynic and N3S modified RC-160 and [TYR3]octreotide (vol 10, pg 437, 1999)
    Decristoforo, C
    Mather, SJ
    BIOCONJUGATE CHEMISTRY, 1999, 10 (04) : 701 - 702
  • [4] 99mTc-labeling of colchicine using [99mTc(CO)3(H2O)3]+ and [99mTc≡N]2+ core for the preparation of potential tumor-targeting agents
    Korde, A
    Satpati, D
    Mathur, A
    Mallia, M
    Banerjee, S
    Kothari, K
    Sarma, HD
    Choudhari, P
    Venkatesh, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (03) : 793 - 799
  • [5] Maillard Glycation of Peptides Containing the (NαHis)Ac Chelator for 99mTc(CO)3 Labeling
    Veronique Maes
    Dirk Tourwé
    International Journal of Peptide Research and Therapeutics, 2006, 12 : 197 - 202
  • [6] Maillard glycation of peptides containing the (NαHis)Ac chelator for 99mTc(CO)3 labeling
    Maes, Veronique
    Tourwe, Dirk
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2006, 12 (03) : 197 - 202
  • [7] 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nα-His)acetic acid-modified [D-Glu1]-minigastrin
    von Guggenberg, E
    Behe, M
    Behr, TM
    Saurer, M
    Seppi, T
    Decristoforo, C
    BIOCONJUGATE CHEMISTRY, 2004, 15 (04) : 864 - 871
  • [8] In vitro and in vivo characterization of an interleukin-15 antagonist peptide by metabolic stability, 99mTc-labeling, and biological activity assays
    Rodriguez-Alvarez, Yunier
    Cabrales-Rico, Ania
    Perera-Pintado, Alejandro
    Prats-Capote, Anais
    Garay-Perez, Hilda E.
    Reyes-Acosta, Osvaldo
    Perez-Garcia, Erik
    Chico-Capote, Araceli
    Santos-Savio, Alicia
    JOURNAL OF PEPTIDE SCIENCE, 2018, 24 (4-5)
  • [9] A novel and simplified route to the synthesis of N3S chelators for 99mTc labeling
    Zhu, Z
    Wang, Y
    Zhang, Y
    Liu, G
    Liu, N
    Rusckowski, M
    Hnatowich, DJ
    NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (06) : 703 - 708
  • [10] Study of chemical kinetics on labeling of 99mTc-N-ethyl-N2S2-Memantine
    CAO Guoxian1
    NuclearScienceandTechniques, 2012, 23 (01) : 52 - 56
12345